Clinical trial
Generalizability of the REDUCE-IT Results to People of South Asian Descent With Known Atherosclerotic Cardiovascular Disease Living in Canada
NCT05271591 is registered in ClinicalTrials.gov with Canadian Medical and Surgical Knowledge Translation Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Generalizability of the REDUCE-IT Results to People of South Asian Descent With Known Atherosclerotic Cardiovascular Disease Living in Canada
- Lead sponsor
- Canadian Medical and Surgical Knowledge Translation Research Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 5, 2022
- Completion date
- April 9, 2022
- Enrollment
- 200 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerotic cardiovascular disease, cardiovascular diseases, coronary heart disease, myocardial infarction